American Society of Retina Specialists (ASRS) 2024
Pegcetacoplan vs Avacincaptad Pegol in Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of Three Phase 3 Trials
Identification of Disease Activity and Therapeutic Response in GA by Human Experts and OCT-Based AI Analysis in Pegcetacoplan therapy
Predictive Role of Outer Retinal Tubulation in Lesion Growth for Subfoveal and Nonsubfoveal Geographic Atrophy
Update on Pegcetacoplan for GA: Clinical Studies and Real-World Experience
Visual Function Benefit of Pegcetacoplan on a Prespecified Microperimetry Endpoint after 36 Months of Continuous Treatment from GALE
Beneficial Effects in Macular Function with Continuous Pegcetacoplan Treatment: OAKS, DERBY, and GALE Open-Label Extension
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.